Aaron Nilsen, Ph.D. - Publications

University of California, Santa Cruz, Santa Cruz, CA, United States 
organic, polymers

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Lawres LA, Garg A, Kumar V, Bruzual I, Forquer IP, Renard I, Virji AZ, Boulard P, Rodriguez EX, Allen AJ, Pou S, Wegmann KW, Winter RW, Nilsen A, Mao J, et al. Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone. The Journal of Experimental Medicine. PMID 27270894 DOI: 10.1084/jem.20151519  1
2016 Stickles AM, Smilkstein MJ, Morrisey JM, Li Y, Forquer IP, Kelly JX, Pou S, Winter RW, Nilsen A, Vaidya AB, Riscoe MK. Atovaquone and ELQ-300 combination therapy: A novel dual-site cytochrome bc1 inhibition strategy for malaria. Antimicrobial Agents and Chemotherapy. PMID 27270285 DOI: 10.1128/AAC.00791-16  1
2015 Sali TM, Pryke KM, Abraham J, Liu A, Archer I, Broeckel R, Staverosky JA, Smith JL, Al-Shammari A, Amsler L, Sheridan K, Nilsen A, Streblow DN, DeFilippis VR. Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses. Plos Pathogens. 11: e1005324. PMID 26646986 DOI: 10.1371/journal.ppat.1005324  1
2015 Miley GP, Pou S, Winter R, Nilsen A, Li Y, Kelly JX, Stickles AM, Mather MW, Forquer IP, Pershing AM, White K, Shackleford D, Saunders J, Chen G, Ting LM, et al. ELQ-300 prodrugs for enhanced delivery and single dose cure of malaria. Antimicrobial Agents and Chemotherapy. PMID 26124159 DOI: 10.1128/AAC.01183-15  1
2015 Stickles AM, Ting LM, Morrisey JM, Li Y, Mather MW, Meermeier E, Pershing AM, Forquer IP, Miley GP, Pou S, Winter RW, Hinrichs DJ, Kelly JX, Kim K, Vaidya AB, ... ... Nilsen A, et al. Inhibition of Cytochrome bc1 as a Strategy for Single-Dose, Multi-Stage Antimalarial Therapy. The American Journal of Tropical Medicine and Hygiene. 92: 1195-201. PMID 25918204 DOI: 10.4269/ajtmh.14-0553  1
2015 Stickles AM, de Almeida MJ, Morrisey JM, Sheridan KA, Forquer IP, Nilsen A, Winter RW, Burrows JN, Fidock DA, Vaidya AB, Riscoe MK. Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum. Antimicrobial Agents and Chemotherapy. 59: 1977-82. PMID 25605352 DOI: 10.1128/AAC.04149-14  1
2014 Nilsen A, Miley GP, Forquer IP, Mather MW, Katneni K, Li Y, Pou S, Pershing AM, Stickles AM, Ryan E, Kelly JX, Doggett JS, White KL, Hinrichs DJ, Winter RW, et al. Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers. Journal of Medicinal Chemistry. 57: 3818-34. PMID 24720377 DOI: 10.1021/jm500147k  1
2013 Nilsen A, LaCrue AN, White KL, Forquer IP, Cross RM, Marfurt J, Mather MW, Delves MJ, Shackleford DM, Saenz FE, Morrisey JM, Steuten J, Mutka T, Li Y, Wirjanata G, et al. Quinolone-3-diarylethers: a new class of antimalarial drug. Science Translational Medicine. 5: 177ra37. PMID 23515079 DOI: 10.1126/scitranslmed.3005029  1
2012 Doggett JS, Nilsen A, Forquer I, Wegmann KW, Jones-Brando L, Yolken RH, Bordón C, Charman SA, Katneni K, Schultz T, Burrows JN, Hinrichs DJ, Meunier B, Carruthers VB, Riscoe MK. Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis. Proceedings of the National Academy of Sciences of the United States of America. 109: 15936-41. PMID 23019377 DOI: 10.1073/pnas.1208069109  1
2012 Pou S, Winter RW, Nilsen A, Kelly JX, Li Y, Doggett JS, Riscoe EW, Wegmann KW, Hinrichs DJ, Riscoe MK. Sontochin as a guide to the development of drugs against chloroquine-resistant malaria. Antimicrobial Agents and Chemotherapy. 56: 3475-80. PMID 22508305 DOI: 10.1128/AAC.00100-12  1
2009 Wood WJL, Geraci T, Nilsen A, DeBarber AE, Scanlan TS. Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo Chembiochem. 10: 361-365. PMID 19105176 DOI: 10.1002/cbic.200800607  1
2007 Nilsen A, England PM. A subtype-selective, use-dependent inhibitor of native AMPA receptors. Journal of the American Chemical Society. 129: 4902-3. PMID 17391037 DOI: 10.1021/ja0705801  1
2007 O'Bryan G, Nilsen A, Braslau R. Ketone functionalized nitroxides: Synthesis, evaluation of N-alkoxyamine initiators, and derivatization of polymer termini Macromolecules. 40: 7848-7854. DOI: 10.1021/ma071039s  1
2007 Ruehl J, Nilsen A, Born S, Thoniyot P, Xu Lp, Chen S, Braslau R. Nitroxide-mediated polymerization to form symmetrical ABA triblock copolymers from a bidirectional alkoxyamine initiator Polymer. 48: 2564-2571. DOI: 10.1016/j.polymer.2007.03.008  1
2006 Nilsen A, Braslau R. Nitroxide decomposition: Implications toward nitroxide design for applications in living free-radical polymerization Journal of Polymer Science, Part a: Polymer Chemistry. 44: 697-717. DOI: 10.1002/pola.21207  1
2005 Braslau R, O'Bryan G, Nilsen A, Henise J, Thongpaisanwong T, Murphy E, Mueller L, Ruehl J. The synthesis and evaluation of new α-hydrogen nitroxides for 'living' free radical polymerization Synthesis. 1496-1506. DOI: 10.1055/s-2005-869894  1
2004 Braslau R, Chaplinski V, Nilsen A, Arulsamy N. Stereochemical studies of chiral acyclic nitroxides coupling with a prochiral radical Synthetic Communications. 34: 2433-2442. DOI: 10.1081/SCC-120039497  1
Show low-probability matches.